IRIS Accounts Production v25.3.0.601 10045887 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100458872024-03-31100458872025-03-31100458872024-04-012025-03-31100458872023-03-31100458872023-04-012024-03-31100458872024-03-3110045887ns15:EnglandWales2024-04-012025-03-3110045887ns14:PoundSterling2024-04-012025-03-3110045887ns10:Director12024-04-012025-03-3110045887ns10:Director22024-04-012025-03-3110045887ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110045887ns10:SmallEntities2024-04-012025-03-3110045887ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3110045887ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110045887ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110045887ns10:FullAccounts2024-04-012025-03-311004588712024-04-012025-03-3110045887ns10:CompanySecretary12024-04-012025-03-3110045887ns10:RegisteredOffice2024-04-012025-03-3110045887ns5:CurrentFinancialInstruments2025-03-3110045887ns5:CurrentFinancialInstruments2024-03-3110045887ns5:Non-currentFinancialInstruments2025-03-3110045887ns5:Non-currentFinancialInstruments2024-03-3110045887ns5:ShareCapital2025-03-3110045887ns5:ShareCapital2024-03-3110045887ns5:RetainedEarningsAccumulatedLosses2025-03-3110045887ns5:RetainedEarningsAccumulatedLosses2024-03-3110045887ns5:NetGoodwill2024-04-012025-03-3110045887ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110045887ns5:NetGoodwill2024-03-3110045887ns5:NetGoodwill2025-03-3110045887ns5:NetGoodwill2024-03-3110045887ns5:PlantMachinery2024-03-3110045887ns5:MotorVehicles2024-03-3110045887ns5:ComputerEquipment2024-03-3110045887ns5:PlantMachinery2024-04-012025-03-3110045887ns5:MotorVehicles2024-04-012025-03-3110045887ns5:ComputerEquipment2024-04-012025-03-3110045887ns5:PlantMachinery2025-03-3110045887ns5:MotorVehicles2025-03-3110045887ns5:ComputerEquipment2025-03-3110045887ns5:PlantMachinery2024-03-3110045887ns5:MotorVehicles2024-03-3110045887ns5:ComputerEquipment2024-03-3110045887ns5:CurrentFinancialInstrumentsns5:WithinOneYear2025-03-3110045887ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-31
REGISTERED NUMBER: 10045887 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

H AND H PHARMA SERVICES LTD

H AND H PHARMA SERVICES LTD (REGISTERED NUMBER: 10045887)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


H AND H PHARMA SERVICES LTD

COMPANY INFORMATION
for the year ended 31 March 2025







DIRECTORS: Miss A K Arshad
I Khan





SECRETARY:





REGISTERED OFFICE: Kirkgate Pharmacy
38 Darley Street
Bradford
West Yorkshire
BD1 3HN





REGISTERED NUMBER: 10045887 (England and Wales)





ACCOUNTANTS: Bannister Prentice Ltd
Beechbrooke
121 Northallerton Road
Northallerton
North Yorkshire
DL6 2PY

H AND H PHARMA SERVICES LTD (REGISTERED NUMBER: 10045887)

BALANCE SHEET
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 58,116 61,990
Tangible assets 5 14,268 15,486
72,384 77,476

CURRENT ASSETS
Stocks 25,400 9,400
Debtors 6 151,964 70,262
Cash at bank 32,066 40,484
209,430 120,146
CREDITORS
Amounts falling due within one year 7 200,747 118,385
NET CURRENT ASSETS 8,683 1,761
TOTAL ASSETS LESS CURRENT
LIABILITIES

81,067

79,237

CREDITORS
Amounts falling due after more than one year 8 52,502 62,478
NET ASSETS 28,565 16,759

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 28,465 16,659
28,565 16,759

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

H AND H PHARMA SERVICES LTD (REGISTERED NUMBER: 10045887)

BALANCE SHEET - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 November 2025 and were signed on its behalf by:




Miss A K Arshad - Director



I Khan - Director


H AND H PHARMA SERVICES LTD (REGISTERED NUMBER: 10045887)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2025

1. STATUTORY INFORMATION

H and H Pharma Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

H AND H PHARMA SERVICES LTD (REGISTERED NUMBER: 10045887)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 77,488
AMORTISATION
At 1 April 2024 15,498
Charge for year 3,874
At 31 March 2025 19,372
NET BOOK VALUE
At 31 March 2025 58,116
At 31 March 2024 61,990

5. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2024
and 31 March 2025 7,641 7,118 9,722 24,481
DEPRECIATION
At 1 April 2024 3,129 5,429 437 8,995
Charge for year 451 422 345 1,218
At 31 March 2025 3,580 5,851 782 10,213
NET BOOK VALUE
At 31 March 2025 4,061 1,267 8,940 14,268
At 31 March 2024 4,512 1,689 9,285 15,486

H AND H PHARMA SERVICES LTD (REGISTERED NUMBER: 10045887)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2025

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 136,353 59,568
Other debtors 15,611 10,694
151,964 70,262

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 21,100 28,939
Trade creditors 108,451 54,027
Taxation and social security 10,617 4,842
Other creditors 60,579 30,577
200,747 118,385

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 52,502 62,478